Petros Pharmaceuticals (NASDAQ:PTPI) Stock Price Up 8.7% – What’s Next?

by · The Cerbat Gem

Petros Pharmaceuticals, Inc. (NASDAQ:PTPI – Get Free Report)’s stock price traded up 8.7% during trading on Tuesday . The stock traded as high as $0.11 and last traded at $0.10. 32,615,548 shares were traded during trading, an increase of 1,470% from the average session volume of 2,076,846 shares. The stock had previously closed at $0.09.

Petros Pharmaceuticals Stock Performance

The stock’s 50 day moving average is $0.25 and its two-hundred day moving average is $0.30. The firm has a market capitalization of $1.16 million, a P/E ratio of -0.02 and a beta of 2.04. The company has a debt-to-equity ratio of 1.58, a current ratio of 0.85 and a quick ratio of 0.74.

About Petros Pharmaceuticals

(Get Free Report)

Petros Pharmaceuticals, Inc, a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED).

Recommended Stories